Stale Pre-tender

RSV 2024

Details

Topic
Immune sera and immunoglobulins
Published
27 November 2023

Tender description

The provision of immunisation products indicated for the prevention or protection from Respiratory Syncytial Virus (RSV) lower respiratory tract disease The contracting authority estimates their requirement for deliveries between 1 July 2024 to 30 June 2026 ('Initial Term') of the contract to be up to 1.6 million doses for Lot 1, up to 1.69 million doses for Lot 2, up to 1.45 million doses for Lot 3 or up to 4 million doses for Lot 4, with the option to extend for up to an additional 24 months.

Timeline

  1. Completed: Pre-tender published27 November 2023
    Current notice

About the buyer

UK Health Security Agency is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33651500 · Immune sera and immunoglobulins
  • 33651600 · Vaccines

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

2 similar open tenders

See more open tenders related to RSV 2024.

Explore all open tenders

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.